CRISPR

 Mirus Bio outlines when to use transfection reagents, viral transduction or electroporation   No single delivery method is ideal for all situations, but researchers may routinely employ a suboptimal approach for the sake of familiarity or to avoid any start-up costs associated with new methods.   The uses of nucleic acid delivery have expanded from recombinant […]

Mirus Bio outlines when to use transfection reagents, viral transduction or electroporation. No single delivery method is ideal for all situations, but researchers may routinely employ a suboptimal approach for the sake of familiarity or to avoid any start-up costs associated with new methods. The uses of nucleic acid delivery have expanded from recombinant gene […]

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna Gawden-Bone, Manager, Cell Based Screening, Horizon […]

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna Gawden-Bone, Manager, Cell Based Screening, Horizon […]

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna Gawden-Bone, Manager, Cell Based Screening, Horizon […]

This is the latest episode of the free DDW podcast, “What does gene-based medicine have to offer?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. The articles are called “Lipidomics in biomedical research: chance and challenges” and “Exploring gene-based medicine’s true potential”. In the first article, Afrisha […]

Genome technology platform provider Jumpcode Genomics has launched technology to improve single cell transcriptional profiling and aid with scientists’ understanding of genomic sequences.   Jumpcode Genomics’ CRISPRclean Single Cell RNA Boost Kit leverages the company’s CRISPR-based technology to remove uninformative sequences from libraries, enhancing single cell experiments and enabling scientists to extract greater insights from genomic […]

DDW’s Megan Thomas spent March 1-2, 2022 at the fourth ‘CRISPR in Drug Discovery: From Targets to Therapeutics’, which took place at Babraham Research Campus in Cambridge, UK. Finding it insightful and eye-opening, she looks forward to the next event on ELRIG’s agenda, ‘Research & Innovation’ at The Kings Centre in Oxford on March 29-30.  […]

Listen to this article on the DDW Podcast: Rosie Bryan & Carlos le Sage, Horizon Discovery, explain how CRISPR-Cas9 technology has become a gold standard for functional genomics.  While efforts in the cancer genomics field have uncovered the mutational landscapes in tumours covering many types of cancer, the functional contribution of the mutated genes to cancer onset and […]

Olivia Hughes from Sphere Fluidics discusses how advances in picodroplet microfluidics, combined with the high efficiency of CRISPR/Cas9 technology, are fuelling a new wave of innovation in the form of a simple click-through workflow for genome editing.  Picodroplet microfluidics is rapidly becoming the technology of choice for high-throughput single cell analysis, providing an easy-to-use tool to isolate single cells in picolitre-volume, […]